Evaluation of anti oxidative effect of linagliptin on type 2 diabetic patients.
Phase of Trial: Phase II
Latest Information Update: 11 Oct 2018
Price : $35 *
At a glance
- Drugs Linagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 04 Oct 2018 Status changed from active, no longer recruiting to completed.
- 30 Mar 2016 Status changed from recruiting to active, no longer recruiting.
- 03 Oct 2014 New trial record